NCT02991690

Brief Summary

This study is a prospective multi-center trial designed to determine the safety profile and efficacy of modest (33ºC) intravascular hypothermia following acute cervical (C1 to C8) Spinal Cord Injury (SCI).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
4mo left

Started Aug 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

7 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress97%
Aug 2017Sep 2026

First Submitted

Initial submission to the registry

December 7, 2016

Completed
6 days until next milestone

First Posted

Study publicly available on registry

December 13, 2016

Completed
8 months until next milestone

Study Start

First participant enrolled

August 4, 2017

Completed
9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2026

Last Updated

November 21, 2025

Status Verified

November 1, 2025

Enrollment Period

9 years

First QC Date

December 7, 2016

Last Update Submit

November 20, 2025

Conditions

Keywords

HypothermiaCervical Spinal Cord InjuryTrauma

Outcome Measures

Primary Outcomes (2)

  • Neurological improvement on American Spinal Injury Association (ASIA)

    Improvement in ASIA Impairment Scale (AIS) after modest hypothermia

    Between baseline and 12 months

  • Neurological improvement on ASIA

    Improvement in ASIA motor score after modest hypothermia

    Between baseline and 12 months

Secondary Outcomes (2)

  • Functional improvement in Functional Independence Measure (FIM)

    12 months

  • Functional improvement in Spinal Cord Independence Measure (SCIM)

    12 months

Study Arms (2)

Hypothermia

EXPERIMENTAL

Intravascular hypothermia will be initiated within 24 hours post-injury and 33 degrees Celsius will be maintained for 48 hours.

Other: Hypothermia

Control

NO INTERVENTION

Standard of care medical treatment, specific to each individual.

Interventions

To deliver intravascular hypothermia, an Alsius Icy CoolGuard® catheter (US Food and Drug Administration approved, Premarket Notification \[510(k), K030421\]; Alsius Corporation, Irvine, California) will be inserted through the femoral vein using a sterile technique. Patients will be cooled at a maximum rate (2-2.5 ºC/hr.) until they reach the target temperature (T 33 ºC), which will be maintained for 48 hours, and then re-warmed at 0.1 ºC/hr. until normothermia (T 37ºC) is achieved.

Hypothermia

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age
  • AIS Grade A - C
  • Glasgow Coma Scale ≥14
  • Able to start hypothermia treatment within 24 hours of injury
  • Non-penetrating injury. Patients urgently taken to the operating room for surgical reduction may also be included.

You may not qualify if:

  • Age \> 70 years
  • AIS Grade D
  • Hyperthermia on admission (\>38.5ºC)
  • Severe systemic injury
  • Severe bleeding
  • Pregnancy
  • Coagulopathy
  • Thrombocytopenia
  • Known prior severe cardiac history
  • Blood dyscrasia
  • Pancreatitis
  • Reynaud's syndrome
  • Cord transection

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (7)

HonorHealth Research Institute with Barrow Brain and Spine

Phoenix, Arizona, 85027, United States

RECRUITING

Jackson Memorial Hospital

Miami, Florida, 33136, United States

RECRUITING

Emory University School of Medicine

Atlanta, Georgia, 30303-3049, United States

TERMINATED

Indiana University School of Medicine

Indianapolis, Indiana, 46202-1000, United States

TERMINATED

University of Maryland School of Medicine

Baltimore, Maryland, 21201, United States

RECRUITING

Thomas Jefferson University

Philadelphia, Pennsylvania, 19107-5125, United States

RECRUITING

Prisma Health - University of South Carolina

Columbia, South Carolina, 29203, United States

RECRUITING

Related Publications (4)

  • Levi AD, Casella G, Green BA, Dietrich WD, Vanni S, Jagid J, Wang MY. Clinical outcomes using modest intravascular hypothermia after acute cervical spinal cord injury. Neurosurgery. 2010 Apr;66(4):670-7. doi: 10.1227/01.NEU.0000367557.77973.5F.

    PMID: 20190669BACKGROUND
  • Dididze M, Green BA, Dietrich WD, Vanni S, Wang MY, Levi AD. Systemic hypothermia in acute cervical spinal cord injury: a case-controlled study. Spinal Cord. 2013 May;51(5):395-400. doi: 10.1038/sc.2012.161. Epub 2012 Dec 18.

    PMID: 23247015BACKGROUND
  • Levi AD, Green BA, Wang MY, Dietrich WD, Brindle T, Vanni S, Casella G, Elhammady G, Jagid J. Clinical application of modest hypothermia after spinal cord injury. J Neurotrauma. 2009 Mar;26(3):407-15. doi: 10.1089/neu.2008.0745.

    PMID: 19271964BACKGROUND
  • Vedantam A, Jimsheleishvili G, Harrop JS, Alberga LR, Ahmad FU, Murphy RK, Jackson JB 3rd, Rodgers RB, Levi AD. A prospective multi-center study comparing the complication profile of modest systemic hypothermia versus normothermia for acute cervical spinal cord injury. Spinal Cord. 2022 Jun;60(6):510-515. doi: 10.1038/s41393-021-00747-w. Epub 2022 Jan 10.

    PMID: 35013548BACKGROUND

MeSH Terms

Conditions

Spinal Cord InjuriesHypothermiaWounds and Injuries

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesTrauma, Nervous SystemBody Temperature ChangesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Allan D Levi, MD, PhD

    University of Miami

    PRINCIPAL INVESTIGATOR

Central Study Contacts

George Jimsheleishvili, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor and Chairman of Neurological Surgery

Study Record Dates

First Submitted

December 7, 2016

First Posted

December 13, 2016

Study Start

August 4, 2017

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

September 1, 2026

Last Updated

November 21, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Locations